PKM2 promotes neutrophil activation and cerebral thrombo-inflammation: Therapeutic implications for ischemic stroke

Nirav Dhanesha; Rakesh B Patel; Prakash Doddapattar; Madankumar Ghatge; Gagan D Flora; Manish Jain; Daniel Thedens; Heena Olalde; Mariia Kumskova; Enrique C Leira; Anil K Chauhan

doi:10.1182/blood.2021012322

Back

PKM2 promotes neutrophil activation and cerebral thrombo-inflammation: Therapeutic implications for ischemic stroke

Journal article

Open access

Peer reviewed

PKM2 promotes neutrophil activation and cerebral thrombo-inflammation: Therapeutic implications for ischemic stroke

Nirav Dhanesha, Rakesh B Patel, Prakash Doddapattar, Madankumar Ghatge, Gagan D Flora, Manish Jain, Daniel Thedens, Heena Olalde, Mariia Kumskova, Enrique C Leira, …

Blood, Vol.139(8), pp.1234-1245

09/15/2021

DOI: 10.1182/blood.2021012322

PMCID: PMC8874361

PMID: 34529778

Files and links (1)

url

https://doi.org/10.1182/blood.2021012322View

Published (Version of record) Open Access

Abstract

There is a critical need for cerebroprotective interventions to improve the suboptimal outcomes of patients with ischemic stroke treated with reperfusion strategies. We found that nuclear pyruvate kinase muscle 2 (PKM2), a modulator of systemic inflammation, was upregulated in neutrophils after the onset of ischemic stroke both in humans and in mice. Therefore, we determined the role of PKM2 in stroke pathogenesis utilizing murine models with preexisting comorbidities. We generated novel myeloid cell-specific PKM2-/- mice on wild-type (PKM2fl/flLysMCre+) and hyperlipidemic background (PKM2fl/flLysMCre+Apoe-/-). Controls were littermate PKM2fl/flLysMCre- or PKM2fl/flLysMCre-Apoe-/- mice. Genetic deletion of PKM2 in myeloid cells limited inflammatory response in peripheral neutrophils and reduced neutrophil extracellular traps following cerebral ischemia/reperfusion, suggesting PKM2 promotes neutrophil hyperactivation in the setting of stroke. In the filament and autologous clot/rtPA stroke models, irrespective of sex, deletion of PKM2 in myeloid cells either in wild-type or hyperlipidemic mice reduced infarcts and enhanced long-term sensorimotor recovery. Laser speckle imaging revealed improved regional cerebral blood flow in myeloid cell-specific PKM2-deficient mice that was concomitant with reduced post-ischemic cerebral thrombo-inflammation (intracerebral fibrin(ogen), platelet (CD41-positive) deposition, neutrophil infiltration, and inflammatory cytokines). Mechanistically, PKM2 regulates post-ischemic inflammation in peripheral neutrophils by promoting STAT3 phosphorylation. To enhance the translational significance, we inhibited PKM2 nuclear translocation using a small molecule and found significantly reduced neutrophil hyperactivation and improved short-term and long-term functional outcomes following stroke. Collectively, these findings identify PKM2 as a novel therapeutic target to improve brain salvage and recovery following reperfusion.

Details

Title: Subtitle: PKM2 promotes neutrophil activation and cerebral thrombo-inflammation: Therapeutic implications for ischemic stroke
Creators: Nirav Dhanesha - Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA
Rakesh B Patel - Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA
Prakash Doddapattar - Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA
Madankumar Ghatge - Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA
Gagan D Flora - Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA
Manish Jain - Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA
Daniel Thedens - Department of Radiology, University of Iowa, Iowa City, Iowa, USA
Heena Olalde - Departments of Neurology, Neurosurgery and Epidemiology, University of Iowa, Iowa City, Iowa, USA
Mariia Kumskova - Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA
Enrique C Leira - Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA
Anil K Chauhan - Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA
Resource Type: Journal article
Publication Details: Blood, Vol.139(8), pp.1234-1245
DOI: 10.1182/blood.2021012322
PMID: 34529778
PMCID: PMC8874361
NLM abbreviation: Blood
ISSN: 0006-4971
eISSN: 1528-0020
Publisher: Elsevier Inc
Language: English
Date published: 09/15/2021
Academic Unit: Neurology; Radiology; Electrical and Computer Engineering; Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Iowa Neuroscience Institute; Neurosurgery; Internal Medicine
Record Identifier: 9984158083402771

Metrics

30 Record Views

126 Times Cited - Web of Science